Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2016
17th World Conference on Lung Cancer
Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria
Presentation Date(s):- Dec 4 - 7, 2016
- Total Presentations: 2466
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
SC04 - EGFR Tyrosine Kinase Inhibitors: A Model for Successful Drug Development
- Type: Science Session
- Track: Chemotherapy/Targeted Therapy/Immunotherapy
- Presentations: 5
- Moderators:S. Thongprasert
- Coordinates: 12/05/2016, 11:00 - 12:30, Hall C7
-
+
SC04.03 - Sequencing of EGFR Tyrosine Kinase Inhibitors
11:40 - 12:00 | Author(s): K. Park
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P1.02 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Biology/Pathology
- Presentations: 87
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P1.02-026 - Detection of Low-Abundant EGFR Somatic Mutations by PNA Clamping-Assisted Fluorescence Melting Curve Analysis
14:30 - 14:30 | Author(s): J. Yoon
- Abstract
Loading...
-
+
P1.05 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Early Stage NSCLC
- Presentations: 79
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P1.05-007 - Analysis of RNA Sequencing Data along with PET SUV-max Can Discover Novel Gene Sets Which Can Predict Surgical Outcome of NSCLC
14:30 - 14:30 | Author(s): Y. Hwang
- Abstract
Loading... -
+
P1.05-048 - Effect of Adjuvant Chemotherapy on the Patterns and Dynamics of Recurrences in Resected Stage II(N1) Lung Adenocarcinoma
14:30 - 14:30 | Author(s): B.J. Park
- Abstract
Loading...
-
+
P1.08 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Surgery
- Presentations: 84
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P1.08-019 - Risk Factors and Survival of Occult N2 Lymph Node Metastasis in NSCLC Patients with Clinical N0-1 Diagnosed by Preoperative PET-CT
14:30 - 14:30 | Author(s): K. Park
- Abstract
Loading...
-
+
MA06 - Locally Advanced NSCLC: Risk Groups, Biological Factors and Treatment Choices
- Type: Mini Oral Session
- Track: Locally Advanced NSCLC
- Presentations: 12
- Moderators:P. Van Houtte
- Coordinates: 12/05/2016, 16:00 - 17:30, Strauss 2
-
+
MA06.03 - Recurrence Dynamics after Trimodality Therapy (Neoadjuvant Chemoradiotherapy and Surgery) in Stage IIIa(N2) Lung Cancer
16:12 - 16:18 | Author(s): J.H. Lee
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
ISS08 - A prIME Oncology Satellite Symposium Supported by Boehringer Ingelheim Pharma GmbH & Co. KG.: Reaching New Heights in the Management of Non-Small Cell Lung Cancer: Focus in EGFR-Targeted Therapy
- Type: Industry Supported Symposium
- Track:
- Presentations: 7
- Moderators:M. Schuler
- Coordinates: 12/05/2016, 17:45 - 19:15, Hall C7
-
+
ISS08.04 - Tackling Acquired Resistance to EGFR– Targeted Therapy: Evaluating Current and Emerging Treatment Strategies
18:20 - 18:30 | Author(s): K. Park
- Abstract
No abstract available for this presentation
-
+
P2.02 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Locally Advanced NSCLC
- Presentations: 62
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.02-044 - Impact of N2 Extent and Nodal Response on Survival after Trimodal Treatment for Stage IIIA-N2 Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): H.K. Kim
- Abstract
Loading...
-
+
OA15 - Sublobar Resections for Early Stage NSCLC
- Type: Oral Session
- Track: Surgery
- Presentations: 8
- Moderators:M.A. Hoda
- Coordinates: 12/06/2016, 16:00 - 17:30, Stolz 2
-
+
OA15.07 - Is Necessary Completion Lobectomy in NSCLC (≤ 2cm) with Visceral Pleural Invasion or Lymphovascular Invasion after Sublobar Resection?
17:05 - 17:15 | Author(s): Y. Moon
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PL04a - Plenary Session: Immune Checkpoint Inhibitors in Advanced NSCLC
- Type: Plenary
- Track: Chemotherapy/Targeted Therapy/Immunotherapy
- Presentations: 5
- Moderators:J. Soria
- Coordinates: 12/07/2016, 08:45 - 09:40, Hall D (Plenary Hall)
-
+
PL04a.02 - OAK, a Randomized Ph III Study of Atezolizumab vs Docetaxel in Patients with Advanced NSCLC: Results from Subgroup Analyses (Abstract under Embargo until December 7, 7:00 CET)
08:55 - 09:05 | Author(s): S.M. Gadgeel
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA23 - EGFR Targeted Therapies in Advanced NSCLC
- Type: Oral Session
- Track: Advanced NSCLC
- Presentations: 8
- Moderators:O.T. Brustugun
- Coordinates: 12/07/2016, 14:20 - 15:50, Stolz 2
-
+
OA23.05 - First-Line Afatinib versus Gefitinib in EGFRm+ Advanced NSCLC: Updated Overall Survival Analysis of LUX-Lung 7
15:05 - 15:15 | Author(s): K. Park
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
